INDIVIOR PLC(INDV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INDV INDIVIOR PLC

休市中 08-07 16:00:00 EDT

38.82

+0.15

+0.39%

盘后38.82

+0.000.00%

19:34 EDT

最高38.91	最低38.08	成交量168.70万
今开38.83	昨收38.67	日振幅2.15%
总市值45.81亿	流通市值42.31亿	总股本1.18亿
成交额6,515万	换手率1.55%	流通股本1.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INDV","market":"US","secType":"STK","nameCN":"INDIVIOR PLC","latestPrice":38.82,"timestamp":1786132800000,"preClose":38.67,"halted":0,"volume":1687043,"hourTrading":{"tag":"盘后","latestPrice":38.82,"preClose":38.82,"latestTime":"19:34 EDT","volume":191763,"amount":7444209.34,"timestamp":1786145650681,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.003878975950349071,"floatShares":109000000,"shares":118000000,"eps":2.766067,"marketStatus":"休市中","change":0.15,"latestTime":"08-07 16:00:00 EDT","open":38.83,"high":38.91,"low":38.08,"amount":65146629.798324,"amplitude":0.021464,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.766067,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":38.67,"preHourTrading":{"tag":"盘前","latestPrice":38.92,"preClose":38.67,"latestTime":"09:29 EDT","volume":146,"amount":5650.821959999999,"timestamp":1786109399999,"change":0.25,"changeRate":0.006465,"amplitude":0.027411},"postHourTrading":{"tag":"盘后","latestPrice":38.82,"preClose":38.82,"latestTime":"19:34 EDT","volume":191763,"amount":7444209.34,"timestamp":1786145650681,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3809570155168473,"impliedVol":0.3718,"impliedVolPercentile":0.1474},"requestUrl":"/m/hq/s/INDV","defaultTab":"news","newsList":[{"id":"1126138791","title":"INDIVIOR PLC：特定情况下若终止合并协议，Supernus须支付1.01亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1126138791","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126138791?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:43","pubTimestamp":1785753788,"startTime":"0","endTime":"0","summary":"INDIVIOR PLC披露了一项关键条款：在特定条件下，倘若合并协议被终止，Supernus公司将必须向该公司支付高达1.01亿美元的终止费用。这一巨额解约费安排，为潜在并购交易增添了新的博弈维度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126840600","title":"Supernus：合并后公司将立即获得规模优势，并预计实现1.25亿美元年度成本协同效应","url":"https://stock-news.laohu8.com/highlight/detail?id=1126840600","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126840600?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:35","pubTimestamp":1785753308,"startTime":"0","endTime":"0","summary":"Supernus Pharmaceuticals 表示，合并后的实体预计将立即受益于规模效应。与此同时，该公司还预期每年可实现高达1.25亿美元的成本协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SUPN","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131807040","title":"Supernus：Indivior Pharmaceuticals 股东将在合并交割前一次性获得总计10亿美元的特别现金股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1131807040","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131807040?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:33","pubTimestamp":1785753239,"startTime":"0","endTime":"0","summary":"Supernus Pharmaceuticals 宣布，Indivior Pharmaceuticals 的股东们将在合并交易正式完成之前，立即获得一笔总额高达10亿美元的一次性特别现金股息。这笔款项将以现金形式发放，旨在合并程序启动前向股东兑现价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV","SUPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146904506","title":"Supernus Pharmaceuticals股东将按每股获得1.5401股Indivior Pharmaceuticals普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1146904506","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146904506?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:32","pubTimestamp":1785753134,"startTime":"0","endTime":"0","summary":"Supernus Pharmaceuticals（SUPN）的股东，即将迎来一项重大资产转换。根据最新披露的信息，他们手中持有的每一股Supernus Pharmaceuticals股份，将对应换取1.5401股Indivior Pharmaceuticals（INDV）的普通股。这一兑换比例，清晰地勾勒出两家公司间交易结构的核心轮廓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","SUPN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115687529","title":"Supernus Pharmaceuticals：Indivior 股东将持有合并后公司约56.5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1115687529","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115687529?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:32","pubTimestamp":1785753134,"startTime":"0","endTime":"0","summary":"Supernus Pharmaceuticals公布，与Indivior的合并交易完成后，Indivior股东将持有合并后实体约56.5%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SUPN","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137788348","title":"Supernus Pharmaceuticals Inc合并后实体将更名为Supernus, Inc.，Jack Khattar出任总裁兼CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1137788348","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137788348?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:31","pubTimestamp":1785753069,"startTime":"0","endTime":"0","summary":"Supernus Pharmaceuticals Inc宣布，其合并后的实体将正式命名为Supernus, Inc.。与此同时，Jack Khattar将担任该公司的总裁兼首席执行官。这一举措标志着公司整合进程中的关键一步，为未来的发展战略奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SUPN","BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166873281","title":"巴克莱银行首次覆盖INDIVIOR PLC，给予“增持”评级及46美元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1166873281","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166873281?lang=zh_cn&edition=full","pubTime":"2026-06-18 18:35","pubTimestamp":1781778955,"startTime":"0","endTime":"0","summary":"巴克莱银行近日启动对INDIVIOR PLC的研究覆盖，并给予该股“增持”评级，同时设定46美元的目标股价。此举标志着这家知名金融机构对INDIVIOR PLC未来前景的积极看法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148881603","title":"INDIVIOR PLC将于2026年6月1日起取消首席科学官职位——根据SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1148881603","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148881603?lang=zh_cn&edition=full","pubTime":"2026-05-16 04:05","pubTimestamp":1778875514,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会（SEC）提交的文件，INDIVIOR PLC决定自2026年6月1日起，正式取消公司内部的首席科学官职位。这一组织结构调整将于指定日期生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141939535","title":"Indivior制药Q1营收3.17亿美元 大幅超越IBES预期2.728亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141939535","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141939535?lang=zh_cn&edition=full","pubTime":"2026-04-30 19:15","pubTimestamp":1777547706,"startTime":"0","endTime":"0","summary":"Indivior制药公布第一季度净利润达8900万美元，业绩表现亮眼。相较于市场预期，公司营收实现显著突破，第一季度营收规模达到3.17亿美元，远超IBES机构预测的2.728亿美元。\n强劲的营收增长凸显了公司核心产品的市场竞争力，同时净利润数据也印证了其高效的运营管理能力。在医药行业面临多重挑战的背景下，这一业绩无疑为投资者注入了信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118042709","title":"INDIVIOR PLC 宣布拟发行4亿美元2031年到期可转换优先票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1118042709","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118042709?lang=zh_cn&edition=full","pubTime":"2026-03-12 19:05","pubTimestamp":1773313546,"startTime":"0","endTime":"0","summary":"INDIVIOR PLC 今日披露，公司计划公开发行总额达4亿美元、于2031年到期的可转换优先票据。此次发行旨在优化公司资本结构，为未来业务拓展提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166617676","title":"INDIVIOR PLC 启动\"加速行动议程\"第二阶段，计划在2026年前全面加速Sublocade推广","url":"https://stock-news.laohu8.com/highlight/detail?id=1166617676","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166617676?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:11","pubTimestamp":1772107885,"startTime":"0","endTime":"0","summary":"INDIVIOR PLC 目前正在推进其\"加速行动议程\"的第二阶段实施工作。该阶段的核心战略包括在2026年之前持续加速旗下产品Sublocade的市场推广进程。这一举措标志着公司对核心产品线的深度聚焦与资源投入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227836","title":"Indivior Plc盘中异动 股价大跌5.05%报9.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227836?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615234,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Indivior Plc股票出现波动，股价大幅下跌5.05%。截至发稿，该股报9.21美元/股，成交量10.7675万股，换手率0.09%，振幅1.70%。Indivior Plc股票所在的制药行业中，整体跌幅为1.61%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、Medicus Pharma Ltd.涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为338.15%、13.89%、10.15%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Sonoma Pharmaceuticals, Inc.、苏轩堂，振幅分别为35.91%、31.15%、29.45%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220035a26a2fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220035a26a2fdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517988604","title":"Indivior Plc盘中异动 急速拉升5.24%报10.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517988604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517988604?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:08","pubTimestamp":1741115333,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时08分，Indivior Plc股票出现异动，股价大幅上涨5.24%。截至发稿，该股报10.05美元/股，成交量121.105万股，换手率0.97%，振幅9.11%。Indivior Plc股票所在的制药行业中，整体跌幅为0.74%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、坎伯兰药业、Esperion Therapeutics, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、大自然药业、Emergent Biosolutions Inc.较为活跃，换手率分别为23.46%、7.90%、7.68%，振幅较大的相关个股有坎伯兰药业、Petros Pharmaceuticals, Inc.、Medicus Pharma Ltd.，振幅分别为30.93%、22.75%、22.63%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305030853abe83bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305030853abe83bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDV","PTPI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516305326","title":"Indivior Plc盘中异动 股价大涨5.03%报9.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516305326?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:08","pubTimestamp":1741014484,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时08分，Indivior Plc股票出现波动，股价急速上涨5.03%。截至发稿，该股报9.71美元/股，成交量52.883万股，换手率0.43%，振幅2.81%。Indivior Plc股票所在的制药行业中，整体涨幅为0.36%。其相关个股中，Sunshine Biopharma Inc C/Wts 、坎伯兰药业、Intercure Ltd.涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、大自然药业较为活跃，换手率分别为7.56%、7.32%、4.64%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Organogenesis Holdings Inc.，振幅分别为30.32%、15.13%、12.08%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032308049637b68a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032308049637b68a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514207943","title":"Indivior Plc盘中异动 大幅跳水5.41%报8.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514207943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514207943?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753038,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，Indivior Plc股票出现异动，股价大幅跳水5.41%。截至发稿，该股报8.40美元/股，成交量5.1113万股，换手率0.04%，振幅0.00%。Indivior Plc股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Organogenesis Holdings Inc.、Ani Pharmaceuticals, Inc.、Collegium Pharmaceutical, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、大自然药业、Quantum Biopharma Ltd.较为活跃，换手率分别为1.68%、1.39%、0.59%，振幅较大的相关个股有Kamada Ltd.、Cronos Group Inc. Common Share、Organogenesis Holdings Inc.，振幅分别为3.62%、2.00%、1.57%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223039abe0e9ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223039abe0e9ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331085","title":"Indivior Plc盘中异动 下午盘大幅上涨5.01%报9.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331085?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:25","pubTimestamp":1740684317,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时25分，Indivior Plc股票出现波动，股价快速拉升5.01%。截至发稿，该股报9.01美元/股，成交量166.503万股，换手率1.34%，振幅7.11%。Indivior Plc股票所在的制药行业中，整体跌幅为0.12%。其相关个股中，Medicus Pharma Ltd.、Cronos Group Inc. Common Share、Therapeuticsmd, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、大自然药业较为活跃，换手率分别为34.16%、15.12%、11.55%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Biofrontera Inc C/Wts 27/10/2026 、Petros Pharmaceuticals, Inc.，振幅分别为49.11%、43.07%、25.88%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280325179632e735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280325179632e735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PTPI","BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514018051","title":"Indivior Plc盘中异动 急速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514018051?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Indivior Plc股票出现异动，股价大幅下挫5.39%。截至发稿，该股报7.81美元/股，成交量3.4644万股，换手率0.03%，振幅0.24%。Indivior Plc股票所在的制药行业中，整体涨幅为0.85%。其相关个股中，Redhill Biopharma Ltd、Petros Pharmaceuticals, Inc.、Medicus Pharma Ltd.涨幅较大，Redhill Biopharma Ltd、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为118.35%、61.87%、12.04%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Petros Pharmaceuticals, Inc.、大自然药业，振幅分别为18.63%、7.66%、6.26%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223117abdc7dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223117abdc7dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDV","PTPI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756130","title":"Indivior Plc2024财年实现净利润-48.00百万美元，同比减少2500.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513756130?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:00","pubTimestamp":1740326425,"startTime":"0","endTime":"0","summary":"2月24日，Indivior Plc公布财报，公告显示公司2024财年净利润为-48.00百万美元，同比减少2500.00%；其中营业收入为11.88亿美元，同比增加8.69%，每股基本收益为-0.36美元。从资产负债表来看，Indivior Plc总负债16.71亿美元，其中短期债务28.00百万美元，资产负债比为0.88，流动比率为0.88。机构评级：截至2025年2月24日，当前有7家机构对Indivior Plc目标价做出预测，其中目标均价为15.45美元，其中最低目标价为13.90美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000038abd9c79b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000038abd9c79b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513212111","title":"Indivior Plc盘中异动 下午盘快速跳水5.01%报8.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513212111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513212111?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:28","pubTimestamp":1740169731,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时28分，Indivior Plc股票出现波动，股价急速跳水5.01%。截至发稿，该股报8.54美元/股，成交量136.452万股，换手率1.10%，振幅5.06%。Indivior Plc股票所在的制药行业中，整体涨幅为1.08%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc C/Wts 、大自然药业涨幅较大，大自然药业、Therapeuticsmd, Inc.、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为4729.17%、117.95%、46.34%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、大自然药业、Sunshine Biopharma Inc C/Wts ，振幅分别为342.76%、120.56%、63.34%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222042851962bc639&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222042851962bc639&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI","UPC","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512965165","title":"Indivior Plc盘中异动 早盘股价大涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512965165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512965165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889196,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Indivior Plc股票出现波动，股价大幅拉升5.80%。截至发稿，该股报10.40美元/股，成交量2.5049万股，换手率0.02%，振幅0.46%。Indivior Plc股票所在的制药行业中，整体涨幅为0.94%。其相关个股中，Painreform Ltd.、Sunshine Biopharma Inc C/Wts 、Quantum Biopharma Ltd.涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、大自然药业较为活跃，换手率分别为2299.88%、58.38%、4.19%，振幅较大的相关个股有Painreform Ltd.、大自然药业、Scilex Holding Company C/Wts 10/11/2027 ，振幅分别为25.53%、7.88%、5.56%。Indivior Plc公司简介：Indivior PLC 是一家专业仿制药生产公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223316abd3af90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223316abd3af90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UPC","INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.indivior.com","stockEarnings":[{"period":"1week","weight":-0.0297},{"period":"1month","weight":-0.0506},{"period":"3month","weight":-0.0172},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.7605},{"period":"ytd","weight":0.0819}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Indivior Pharmaceuticals, Inc.于2014年9月26日在英格兰和威尔士的法律下注册成立为一家公共有限公司，并于2026年1月26日在特拉华州重新注册。Indivior致力于通过研发治疗阿片类药物使用障碍（OUD）的药物来改善患者的生活。基于其现有的OUD治疗产品组合，Indivior拥有一系列候选产品，旨在进一步拓展其在该领域的业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.021864},{"month":2,"riseRate":0.583333,"avgChangeRate":0.011788},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.007447},{"month":4,"riseRate":0.833333,"avgChangeRate":0.037804},{"month":5,"riseRate":0.833333,"avgChangeRate":0.065087},{"month":6,"riseRate":0.5,"avgChangeRate":0.060391},{"month":7,"riseRate":0.727273,"avgChangeRate":0.153964},{"month":8,"riseRate":0.5,"avgChangeRate":-0.015659},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.095405},{"month":10,"riseRate":0.363636,"avgChangeRate":0.007009},{"month":11,"riseRate":0.545455,"avgChangeRate":0.010295},{"month":12,"riseRate":0.636364,"avgChangeRate":0.020229}],"exchange":"NASDAQ","name":"INDIVIOR PLC","nameEN":"INDIVIOR PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INDIVIOR PLC(INDV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供INDIVIOR PLC(INDV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"INDIVIOR PLC,INDV,INDIVIOR PLC股票,INDIVIOR PLC股票老虎,INDIVIOR PLC股票老虎国际,INDIVIOR PLC行情,INDIVIOR PLC股票行情,INDIVIOR PLC股价,INDIVIOR PLC股市,INDIVIOR PLC股票价格,INDIVIOR PLC股票交易,INDIVIOR PLC股票购买,INDIVIOR PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INDIVIOR PLC(INDV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供INDIVIOR PLC(INDV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}